Trial · NCT04800172
The Possible Effects of Roflumilast on Obesity Related Disorders
NCT04800172, Phase 3, Completed, Tanta University
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. The Possible Effects of Roflumilast on Obesity Related Disorders. Trials, record NCT04800172. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT04800172
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- The Possible Effects of Roflumilast on Obesity Related Disorders
- NCT number
- NCT04800172
- Status
- Completed
- Phases
- Phase 3
- Enrollment
- 66 participants, actual
- Lead sponsor
- Tanta University
- Conditions
- Obesity, PreDiabetes
- Interventions
- Roflumilast, placebo
- First posted
- 2021-03-16
- Last updated
- 2022-04-05
Source ClinicalTrials.gov
Registered outcomes7
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change in patients body weight | baseline and 3 months later | substracting pre-treatment from post-treatment values. |
| Primary | Change in blood glucose | baseline and 3 months later | using glucose oxidase method for assessment of blood glucose and substracting pre-treatment from post-treatment values. |
| Primary | Change in plasma insulin level | baseline and 3 months later | substracting pre-treatment from post-treatment values of plasma insulin. |
| Primary | Change in HOMA-IR index | baseline and 3 months later | HOMA-IR will be calculated for all patients at baseline and 3 months later. |
| Primary | Change in blood lipid levels | baseline and 3 months later | blood lipid levels will be measured at baseline and 3 months after treatment including total cholesterol, triglycerides, HDL-C and LDL-C. |
| Secondary | Changes in TNF-alfa serum level | baseline and 3 months later | substracting pre-treatment from post-treatment values of TNF-alfa. |
| Secondary | Changes in malondialdehyde serum level (MDA) | baseline and 3 months later | substracting pre-treatment from post-treatment values of MDA. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT04800172
GET https://conductscience.org/api/trials/v1/NCT04800172/registered